The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No ClinVar Id was directly found from the curated document


Variant: NM_000261.2:c.1085del

CA2017997725

Gene: MYOC
Condition: primary open angle glaucoma
Inheritance Mode: Autosomal dominant inheritance
UUID: 54408923-2098-4b7d-b84b-3cae99810070

HGVS expressions

NM_000261.2:c.1085del
NC_000001.11:g.171636356del
CM000663.2:g.171636356del
NC_000001.10:g.171605496del
CM000663.1:g.171605496del
NC_000001.9:g.169872119del
NG_008859.1:g.21279del
ENST00000037502.11:c.1085del
ENST00000637303.1:c.235-2274del
ENST00000638471.1:c.*423del
ENST00000037502.10:c.1085del
ENST00000614688.1:c.*49del
NM_000261.1:c.1085del

Uncertain Significance

Met criteria codes 3
PP1 PM4 PM2_Supporting
Not Met criteria codes 12
PS2 PS1 PS3 PS4 BP4 BP7 BA1 PP3 PM5 PM6 BS3 BS1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Glaucoma Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 1.1

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Glaucoma VCEP
The c.1085del variant in MYOC is a deletion of a single nucleotide, predicted to encode a frameshift with consequent premature termination of the protein at codon 45 of the frameshift, or amino acid 406 (p.Gly362GlufsTer45). This variant is predicted to involve ≥ 10% of the protein within the conserved olfactomedin domain, meeting PM4. This variant was not found in any population of gnomAD (v2.1.1), meeting the ≤ 0.0001 threshold set for PM2_Supporting in a population of at least 10,000 alleles. There was no computational or functional evidence predicting a damaging or benign impact of this variant on MYOC function. 4 segregations in 1 family, with primary open angle glaucoma (POAG), have been reported (PMID: 19688280), which fulfilled PP1 (3-4 meioses). Only 1 proband with POAG had been reported (PMID: 19688280), not meeting the ≥ 2 probands threshold required to meet PS4_Supporting. In summary, this variant met the criteria to receive a score of 4 and to be classified as a variant of uncertain significance (uncertain significance classification range -1 to 5) for primary open angle glaucoma based on the ACMG/AMP criteria met, as specified by the ClinGen Glaucoma VCEP (v1, 12 Oct 2021): PM4, PP1, PM2_Supporting.
Met criteria codes
PP1
4 segregations in 1 family, with POAG, have been reported (PMID: 19688280), which fulfilled PP1 (3-4 meioses).
PM4
This deletion is predicted to involve ≥ 10% of the protein and is within the conserved olfactomedin domain.
PM2_Supporting
This variant was not found in any population of gnomAD (v2.1.1), meeting the ≤ 0.0001 threshold set for PM2_Supporting in a population of at least 10,000 alleles.
Not Met criteria codes
PS2
This variant has not been identified de novo.
PS1
This variant does not involve an amino acid change.
PS3
No functional evidence has been found for this variant.
PS4
Only 1 proband with POAG had been reported (PMID: 19688280), not meeting the ≥ 2 probands threshold required to meet PS4_Supporting.
BP4
This is not a missense, synonymous or non-coding variant.
BP7
This is not a synonymous or non-coding variant.
BA1
This criterion was not met as PM2_Supporting has been met.
PP3
This is not a missense variant.
PM5
This is not a missense variant.
PM6
This variant has not been identified de novo.
BS3
No functional evidence has been found for this variant.
BS1
This criterion was not met as PM2_Supporting has been met.
Approved on: 2023-08-08
Published on: 2023-08-08
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.